Samsung Biologics Co.,Ltd. (KRX: 207940)
South Korea
· Delayed Price · Currency is KRW 1,072,000
-23,000 (-2.10%)
Feb 4, 2025, 9:00 AM KST
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 76.30 trillion as of February 4, 2025. Its market cap has increased by 39.22% in one year.
Market Cap
76.30T
Enterprise Value
76.28T
Revenue
4.36T
Ranking
n/a
PE Ratio
72.49
Stock Price
1,072,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 76.30T, an increase of 700.80%. That is a compound annual growth rate of 28.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 38.12T |
| Yuhan | 9,703.80B |
| SK Biopharmaceuticals | 8,543.98B |
| SK bioscience Co.,Ltd. | 3,839.02B |
| Hanmi Pharm. | 3,093.97B |
| Hanall Biopharma | 2,066.44B |
| Hanmi Science | 1,875.67B |
| Daewoong Pharmaceutical | 1,584.41B |